Zydus Lifesciences bags USFDA approval for Empagliflozin, Metformin Hydrochloride Tablets Ruchika Sharma11 July 2022 12:23 PM ISTThe drug will be manufactured at the group’s formulation facility at SEZ, Ahmedabad, India.
Boehringer Ingelheim, Evotec and bioMérieux launch joint venture Aurobac Ruchika Sharma10 July 2022 2:00 PM ISTFrance: Boehringer Ingelheim, a research-driven biopharmaceutical company, the life science company Evotec SE and bioMérieux have announced that they...
Merck in advanced talks to buy Seagen in nearly USD 40-billion deal: WSJ Ruchika Sharma10 July 2022 12:00 PM ISTThe companies are seeking to seal the deal on or before the announcement of Merck's second-quarter earnings set for July 28, according to the WSJ...
Pharma businesses with strong quality compliance to emerge stronger as pandemic impact decreases, says Ajay Piramal Ruchika Sharma10 July 2022 10:00 AM ISTNew Delhi: Pharmaceutical businesses that have a strong track record of quality compliance and can remain agile towards new regulatory requirements,...
Intercept to go back to USFDA with its NASH treatment application Ruchika Sharma10 July 2022 9:30 AM ISTNew Jersey: Intercept Pharmaceuticals Inc will resubmit its application for approval of its therapy for a chronic liver disease to the U.S. Food and...
Dr Reddy's Labs launches Fesoterodine Fumarate Extended-Release Tablets in US Ruchika Sharma9 July 2022 2:55 PM ISTHyderabad: Drugmaker, Dr. Reddy's Laboratories Ltd., has announced the launch of the company's Fesoterodine Fumarate Extended-Release Tablets, a...
Pfizer-BioNTech gets USFDA nod for COVID vaccine Comirnaty for adolescents 12 through 15 years of age Ruchika Sharma9 July 2022 1:45 PM ISTCOMIRNATY (COVID-19 Vaccine, mRNA) is a vaccine approved for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute...
Zydus Lifesciences unveils anti-diabetic drug molecule Sitagliptin in India Ruchika Sharma9 July 2022 12:00 PM ISTSitagliptin is the gold standard in the Dipeptidyl peptidase 4 inhibitor (DPP4i) category with over 62% market share in the global market.
Dr Reddys aims to triple reach to 1.5 billion patients by 2030 Ruchika Sharma9 July 2022 11:00 AM ISTDr Reddy's said it is making its "products accessible and affordable for patients" and "25 percent of new launches to be first to market by 2027".
Zydus Wellness proactively looking for acquisitions; to enter new overseas markets Ruchika Sharma9 July 2022 10:00 AM ISTZydus Wellness has integrated the business of Heinz, including a portfolio of popular brands Complan, Glucon-D and Nycil, which it had acquired in a...
Roche gets USFDA priority review for Lunsumio to treat relapsed or refractory follicular lymphoma Ruchika Sharma8 July 2022 5:30 PM ISTPriority Review designation is granted to medicines that the FDA considers to have the potential to provide significant improvements in the safety and...
USFDA authorizes pharmacists to prescribe Pfizer COVID drug Paxlovid Ruchika Sharma8 July 2022 2:30 PM ISTThe agency said patients who tested positive for COVID-19 should bring their health records for the pharmacists to review for kidney and liver...
